학술논문

Real-world data on the use of ocrelizumab, among ms patients: b-cell suppression and clinical outcomes
Document Type
Journal
Source
MULTIPLE SCLEROSIS JOURNAL; DEC 2020, 26 3_SUPPL, p185-p186, 2p. Supplement: 3_
Subject
Language
English
ISSN
14770970